TMC207: Promising new drug for tuberculosis
Submitted by Bobby Ramakant (bobby) about 3 days ago
Addition of the new drug, TMC207 to standard multidrug-resistant TB (MDR-TB) treatment regimens dramatically cuts the period from when patients start treatment to their sputum testing negative for TB. This new drug, TMC207 is being developed by a pharmaceutical research company, Tibotec, in collaboration with TB Alliance. Read more...
Keywords: drug resistance extensively drug-resistant M/XDR-TB MDR-TB multi-drug resistant research TB TMC207 tuberculosis XDR-TB














